首页> 外文期刊>BMC proceedings. >Personalized medicine and Hispanic health: improving health outcomes and reducing health disparities – a National Heart, Lung, and Blood Institute workshop report
【24h】

Personalized medicine and Hispanic health: improving health outcomes and reducing health disparities – a National Heart, Lung, and Blood Institute workshop report

机译:个性化医学和西班牙裔健康:改善健康状况并减少健康差异–美国国家心肺血液研究所研讨会报告

获取原文
           

摘要

Persons of Hispanic/Latino descent may represent different ancestries, ethnic and cultural groups and countries of birth. In the U.S., the Hispanic/Latino population is projected to constitute 29% of the population by 2060. A personalized approach focusing on individual variability in genetics, environment, lifestyle and socioeconomic determinants of health may advance the understanding of some of the major factors contributing to the health disparities experienced by Hispanics/Latinos and other groups in the U.S., thus leading to new strategies that improve health care outcomes. However, there are major gaps in our current knowledge about how personalized medicine can shape health outcomes among Hispanics/Latinos and address the potential factors that may explain the observed differences within this heterogeneous group, and between this group and other U.S. demographic groups. For that purpose, the National Heart, Lung, and Blood Institute (NHLBI), in collaboration with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the Food and Drug Administration (FDA), held a workshop in which experts discussed (1) potential approaches to study medical treatments and health outcomes among Hispanics/Latinos and garner the necessary evidence to fill gaps of efficacy, effectiveness and safety of therapies for heart, lung, blood and sleep (HLBS) disorders and conditions--and their risk factors; (2) research opportunities related to personalized medicine to improve knowledge and develop effective interventions to reduce health disparities among Hispanics/Latinos in the U.S.; and (3) the incorporation of expanded sociocultural and socioeconomic data collection and genetic/genomic/epigenetic information of Hispanic/Latino patients into their clinical assessments, to account for individual variability in ancestry; physiology or disease risk; culture; environment; lifestyle; and socioeconomic determinants of health. The experts also provided recommendations on: sources of Hispanic/Latino health data and strategies to enhance its collection; policy; genetics, genomics and epigenetics research; and integrating Hispanic/Latino health research within clinical settings.
机译:西班牙裔/拉丁美洲裔的人可以代表不同的祖先,种族和文化群体以及出生国家。在美国,到2060年,西班牙裔/拉丁美洲裔人口预计将占总人口的29%。着重研究遗传学,环境,生活方式和健康的社会经济决定因素的个体差异的个性化方法可能会增进对某些主要因素的理解针对西班牙裔/拉丁裔和美国其他人群所经历的健康差异,从而提出了改善医疗结果的新策略。但是,我们目前在有关个性化医学如何影响西班牙裔/拉丁美洲人健康状况并解决可能解释该异类人群以及该人群与其他美国人口统计学人群之间的差异的潜在因素方面存在重大差距。为此,美国国立心脏,肺和血液研究所(NHLBI)与美国糖尿病,消化与肾病研究所(NIDDK)和美国食品药品管理局(FDA)合作举办了一个研讨会,专家讨论了(1)研究西班牙裔/拉丁裔之间的医学治疗和健康结局的潜在方法,并获得了必要的证据来填补心脏,肺,血液和睡眠(HLBS)疾病和病症的疗效,有效性和安全性方面的空白-以及他们的危险因素; (2)与个性化医学相关的研究机会,以提高知识水平并制定有效的干预措施,以减少美国西班牙裔/拉丁裔之间的健康差异; (3)将扩大的西班牙裔/拉丁美洲裔患者的社会文化和社会经济数据收集以及遗传/基因组/表观遗传信息纳入其临床评估中,以解决血统的个体差异;生理或疾病风险;文化;环境;生活方式;以及健康的社会经济决定因素。专家们还就以下方面提出了建议:西班牙裔/拉丁美洲裔健康数据的来源以及加强收集的策略;政策;遗传学,基因组学和表观遗传学研究;并将西班牙裔/拉丁美洲裔健康研究整合到临床环境中。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号